发明名称 |
ARTIFICIAL TRANSCRIPTION FACTORS ENGINEERED TO OVERCOME ENDOSOMAL ENTRAPMENT |
摘要 |
The invention relates to an artificial transcription factor comprising a polydactyl zinc finger protein targeting specifically a gene promoter, engineered to overcome endosomal entrapment after transduction into cells. Such artificial transcription factor comprises a polydactyl zinc finger protein fused to an inhibitory or activatory protein domain, a nuclear localization sequence, a protein transduction domain, and an endosome-specific protease-recognition site. These transducible artificial transcription factors are particularly useful for the treatment of diseases caused or modulated by membrane-bound receptor proteins, nuclear receptor proteins or products of haploinsufficient genes. |
申请公布号 |
US2016046682(A1) |
申请公布日期 |
2016.02.18 |
申请号 |
US201414781701 |
申请日期 |
2014.04.02 |
申请人 |
ALIOPHTHA AG |
发明人 |
NEUTZNER Albert;FLAMMER Josef;HUXLEY Alice |
分类号 |
C07K14/47 |
主分类号 |
C07K14/47 |
代理机构 |
|
代理人 |
|
主权项 |
1. An artificial transcription factor comprising a polydactyl zinc finger protein targeting specifically a gene promoter fused to an activatory or inhibitory protein domain, a nuclear localization sequence, a protein transduction domain, and an endosome-specific protease recognition site. |
地址 |
Basel CH |